These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 21193188

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.
    Arikan S, Akay H, Bahceci M, Tuzcu A, Gokalp D.
    Fertil Steril; 2009 Feb; 91(2):450-5. PubMed ID: 18501898
    [Abstract] [Full Text] [Related]

  • 3. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI, Bulbul E, Adali E, Hismiogulları AA, Inceboz U.
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS.
    Bayrak T, Dursun P, Bayrak A, Gültekin M, Kolusarı A, Cakır E, Ozyurt M, Zeyneloğlu HB.
    Gynecol Endocrinol; 2012 Nov; 28(11):874-8. PubMed ID: 22621680
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.
    Pepene CE, Ilie IR, Marian I, Duncea I.
    Eur J Endocrinol; 2011 Jan; 164(1):61-8. PubMed ID: 20974706
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.
    Sorensen MB, Franks S, Robertson C, Pennell DJ, Collins P.
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):655-9. PubMed ID: 17054469
    [Abstract] [Full Text] [Related]

  • 12. Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.
    Mancini F, Cianciosi A, Reggiani GM, Facchinetti F, Battaglia C, de Aloysio D.
    Fertil Steril; 2009 Jun; 91(6):2537-44. PubMed ID: 18462732
    [Abstract] [Full Text] [Related]

  • 13. Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome.
    Yildizhan R, Ilhan GA, Yildizhan B, Kolusari A, Adali E, Bugdayci G.
    Fertil Steril; 2011 Jul; 96(1):246-50. PubMed ID: 21600576
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia.
    Vladimirova-Kitova L, Deneva T, Angelova E, Nikolov F, Marinov B, Mateva N.
    Clin Physiol Funct Imaging; 2008 Nov; 28(6):417-25. PubMed ID: 18798847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.